NanoSphere Health Sciences Inc.
NSHS
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 47.75% | 9.49% | -11.06% | 13.51% | -35.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.86% | 9.49% | -11.06% | 13.51% | -38.77% |
| Operating Income | -33.86% | -9.49% | 11.06% | -13.51% | 38.77% |
| Income Before Tax | -234.75% | 51.44% | -90.50% | 77.22% | 76.92% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -234.75% | 51.44% | -90.50% | 77.22% | 76.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -234.75% | 51.44% | -90.50% | 77.22% | 76.92% |
| EBIT | -33.86% | -9.49% | 11.06% | -13.51% | 38.77% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -228.57% | 51.58% | -90.43% | 78.05% | 76.27% |
| Normalized Basic EPS | -190.00% | 50.85% | 46.55% | 72.00% | 72.97% |
| EPS Diluted | -228.57% | 51.58% | -90.43% | 78.05% | 76.27% |
| Normalized Diluted EPS | -190.00% | 50.85% | 46.55% | 72.00% | 72.97% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |